Table 1.
Demographics
| Variable | No. (%) |
|---|---|
| Patient characteristics, N = 8388 | |
| Sex | |
| Women | 4799 (57) |
| Men | 3589 (43) |
| Pathology | |
| Adenocarcinoma | 4142 (49) |
| NSCLC‐NOS | 4246 (51) |
| ctDNA alterations detected | |
| Yes | 7301 (87) |
| No | 1087 (13) |
| Panel version a | |
| 54‐Gene panel | 358 (4) |
| 68‐Gene panel | 2230 (26) |
| 70‐Gene panel | 6087 (70) |
| Sample characteristics, N = 9202 | |
| Panel version | |
| 54‐Gene panel | 361 (4) |
| 68‐Gene panel | 2345 (25) |
| 70‐Gene panel | 6496 (71) |
| ctDNA alterations detected | |
| Yes | 7921 (86) |
| No | 1281 (14) |
Abbreviations: ctDNA, circulating tumor DNA; NSCLC‐NOS, non–small cell lung cancer, not otherwise specified.
a
Some patients had ctDNA analysis at more than 1 time point, some with different panel versions.